VR17-04, a metabolite of Enisamium, inhibits the incorporation of GTP and UTP during RNA synthesis. Its mechanism of action was elucidated through docking and molecular dynamics simulations. These findings suggest that VR17-04 could serve as a potential antiviral strategy for managing COVID-19.
Molecular Weight:
243.28
CAS Number:
[2417925-64-3]
Formula:
C14H15N2O2
T202911
* VAT and and shipping costs not included. Errors and price changes excepted
